Until now, it has been suggested that two doses of the vaccine are needed to make antibodies against corona. However, a new study reveals something new.
New Delhi 04 May: Corona vaccine in many places around the world (Corona Vaccine) Are studying. Many new things are emerging from this study. So far, it is thought to be an anti-corona antibody (Antibodies) Both doses of vaccine for making (Two Dose of Vaccine) It is necessary to take. However, a new study reveals something new. This suggests that even a single dose of the vaccine is sufficient for people who have already had corona. In the case of such people, even a single dose of the corona vaccine helps them to fight the virus.
The study was conducted by scientists from Imperial College London, Queen Mary University and University College. The research is published in the journal Science. It is claimed that people who have already had coronary heart disease find adequate antibodies in their body only after taking a single dose of the vaccine. The scientists performed the study on a South African variant. He hopes that the same will apply to Brazil (P.1) as well as Indian (B.1.617) and (B.1.618) variants.
Scientists have used the Pfizer-Bioentech vaccine for this study. The study found that a single dose of the vaccine was sufficient for people who had already had coronary heart disease or who had mild or no symptoms of coronary heart disease. However, people who have not had a corona before had a lower level of immunity after a single dose and were at higher risk of developing a corona.
Beed News: Exiting Covid Center cost patients dearly, finally filing a case
“Our study shows that people who have received a single dose of the vaccine and have not had a corona before are at risk of developing a new strain,” said Rosemer Boyton, a professor at Imperial College. That’s why people need to take both doses, he said. He further said that new strains are coming up. More and more people need to be vaccinated. In such cases, people who have already had corona may benefit from a single dose of the vaccine.